3-(4-bromophenyl)-5-methyl-1,2,4-oxadiazole,
118183-92-9,
4-(5-Methyl-1,2,4-oxadiazol-3-yl)bromobenzene,
AC1LGLT8,
ACMC-1CE2Y,
SCHEMBL1170085,
CTK4B0599,
DTXSID50356408,
YWBIOYGLRGIJRT-UHFFFAOYSA-N,
ZINC341621,
KS-000019QH,
ANW-17099,
MFCD00487341,
SBB099046,
AKOS015835650,
MCULE-2497190099,
RP05801,
RTR-003143,
AJ-19945,
AN-32987,
SY025145,
ZB010949,
AB0034984,
DB-030641,
ST2404761,
CS-0035520,
FT-0711744,
ST50992266,
X9249,
EN300-79237,
MFCD00487341 (95%),
3-(4-bromophenyl)-5-methyl-1,2,4oxadiazole,
A-5242,
1,2,4-Oxadiazole, 3-(4-bromophenyl)-5-methyl-,
1,2,4-Oxadiazole,3-(4-bromophenyl)-5-methyl-,
183B929,
3-(4-bromo-phenyl)-5-methyl-[1,2,4]oxadiazole,
3-(4-Bromophenyl)-5-methyl-[1,2,4]oxadiazole,
1-bromo-4-(5-methyl-1,2,4-oxadiazol-3-yl)benzene,
I14-39552,
3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole, AldrichCPR,
C9H7BrN2O,
CID823560,
ZINC00341621,
CS-4061,
4-[trans-4-(trans-4-Ethylcyclohexyl)cyclohexyl]-1,2-difluorobenzene,